Nakashima, Masayuki
Li, Kan
Chen, Qichen
de Silva, Sajith
Li, Hal
Kawakami, Koji
Wei, Qingyi
Luo, Sheng
Zhao, Hong
Article History
Received: 8 August 2023
Accepted: 5 December 2023
First Online: 21 December 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The Ethics Committee of the Graduate School and Faculty of Medicine, Kyoto University approved the study (November 18, 2020, approval number: R2719)<b> ,</b> and waived the requirement for an informed consent due to the anonymous nature of the data.
: Not applicable.
: K.K. received an advisory fee from Shin Nippon Biomedical Laboratories, Ltd., JMDC Inc., AGREE Inc.; research funds from Sumitomo Dainippon Pharma Co, Ltd., Pfizer Inc., Stella Pharma Corporation, CMIC Co., Ltd., Suntory Beverage & Food Ltd., Medical Platform Co., Ltd., and Real World Data, Co., Ltd.; and holds stocks in Real World Data, Co., Ltd. There are no patent products under development or marketed products to declare relevant to these companies. Other authors declare that they have no competing interests.